Randomized study of chemoembolization as an adjuvant therapy for primary liver carcinoma after hepatectomy
Authors:
- 1 June 1995
- journal article
- clinical trial
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 121 (6) , 364-366
Abstract
From April 1990 to December 1993, 140 patients were recruited to a randomized study to evaluate transcatheter hepatic arterial chemoembolization (TACE) as an adjuvant therapy for primary liver carcinoma after hepatectomy. This study investigated the principle, techniques and results of TACE. The results showed that the intrahepatic recurrence rate was 48.9% in the patients who underwent radical resection only, but only 21.3% in the patients who also underwent TACE 3–4 weeks after hepatectomy (PPP<0.001).Keywords
This publication has 5 references indexed in Scilit:
- Growth and spread of hepatocellular carcinoma: A review of 240 consecutive autopsy casesCancer, 1990
- Prognostic factors after hepatectomy for hepatocellular carcinomas. A univariate and multivariate analysisCancer, 1990
- Subclinical primary liver carcinomaJournal of Surgical Oncology, 1989
- ADVERSE-EFFECTS OF PREOPERATIVE HEPATIC-ARTERY CHEMOEMBOLIZATION FOR RESECTABLE HEPATOCELLULAR-CARCINOMA - A RETROSPECTIVE COMPARISON OF 138 LIVER RESECTIONS1989
- Pathology of Hepatocellular Carcinoma1987